79259181

Information

• Trademark
• 79259181

• Source

• Serial Number

  79259181

• Registration Number

  6144117

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  March 22, 2019
  5 years ago

• Registration Date

  September 08, 2020
  4 years ago

• Transaction Date

  August 08, 2022
  2 years ago

• Status Date

  September 08, 2020
  4 years ago

• Published for Opposition Date

  June 23, 2020
  4 years ago

• Location Date

  September 08, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  LIEBL, ALEXANDRA SUARE

• Attorney Docket Number

  T-4483 US MP

  Attorney Name

  Joi A. White

  Law Office Assigned Location Code

  N20

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• DM0000: The mark consists of an incomplete circle with a horizontal bar at its top and bottom. The circle and horizontal bars are divided in the center as to appear as two mirroring geometric shapes.
• GS0051: Pharmaceutical and veterinary preparations and substances consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; chemical reagents for medical and veterinary use; nucleic acid sequences amplification reagents for medical use; nucleic acid sequences for medical purposes; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; enzyme preparations for pharmaceutical, veterinary and medical purposes; medical kits containing medical and pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostic preparations for medical or veterinary use; biological chemical diagnostic test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
• CC0000: Color is not claimed as a feature of the mark.
• GS0011: Chemical preparations used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants for non-medical purpose; enzyme preparations for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; amino acids for laboratory or research use; DNA polymerase; chemical enzymes for use in the processing and screening of food; chemicals used in environmental monitoring
• GS0441: Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease in the field of detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; genetic testing for medical purposes; medical and health care services in the field of dna, genetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes
• GS0101: Surgical apparatus and instruments; medical and veterinary apparatus and instruments being diagnostic testing apparatus and instruments for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits consisting primarily of diagnostic testing apparatus and instruments for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; point of care medical devices being diagnostic testing apparatus for the purpose of detecting antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; medical screening kits comprised of medical screening and testing apparatus for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired and inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy
• GS0421: Scientific and technological services and research and design relating thereto, namely, DNA analysis services for scientific research purposes, scientific research consulting in the field of genetics; scientific research in the field of genetics; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research in the field of chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; medical research in the field of diagnostic imaging and molecular medicine; research relating to molecular sciences; research and analysis of data generated by scientific and medical experiments and tests being data for the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; biological, bacteriological, chemical, biochemical, dna, rna, protein, polynucleic acid and molecular analysis and evaluation services for scientific and research purposes for scientific and research purposes; dna and rna and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genetic mapping for scientific purposes, namely, genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of the diagnosis of disease, detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy; molecular diagnostics testing

Case File Event Statements

• 8/8/2022 - 2 years ago

  36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 8/8/2022 - 2 years ago

  35 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/8/2022 - 2 years ago

  34 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 8/13/2021 - 3 years ago

  33 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 1/15/2021 - 3 years ago

  32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 12/26/2020 - 3 years ago

  31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 12/26/2020 - 3 years ago

  30 - FINAL DISPOSITION PROCESSED Type: FIMP

• 12/8/2020 - 4 years ago

  29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/8/2020 - 4 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/23/2020 - 4 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/23/2020 - 4 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/19/2020 - 4 years ago

  25 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 6/3/2020 - 4 years ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 6/3/2020 - 4 years ago

  23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 6/3/2020 - 4 years ago

  22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/16/2020 - 4 years ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/15/2020 - 4 years ago

  20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 5/14/2020 - 4 years ago

  19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/14/2020 - 4 years ago

  18 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 1/9/2020 - 4 years ago

  17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 1/9/2020 - 4 years ago

  16 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/9/2020 - 4 years ago

  15 - FINAL REFUSAL WRITTEN Type: CNFR

• 12/19/2019 - 5 years ago

  14 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/19/2019 - 5 years ago

  13 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/19/2019 - 5 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/18/2019 - 5 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/18/2019 - 5 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/12/2019 - 5 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 6/25/2019 - 5 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/25/2019 - 5 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/6/2019 - 5 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/5/2019 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/3/2019 - 5 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/1/2019 - 5 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/28/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 5/23/2019 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR